Skip to content

NovAccess Global Inc.: 10-Q filed 2024-05-15

What NovAccess Global Inc. reported in its quarterly report filed 2024-05-15 (fiscal Q2 2024): 31 published measures, 98 facts as tagged in accession 0001185185-24-000506.

This filing

Form
10-Q (quarterly report)
Filed
2024-05-15
Fiscal period
fiscal Q2 2024
Accession
0001185185-24-000506 on SEC EDGAR

Values are as tagged in this filing. A later filing can restate them; each measure links to its history page, which shows the latest-filed value per period. All NovAccess Global Inc. filings.

Reported measures

Total assets

Resources recognized on the balance sheet. Book assets are not the market value of the business.

PeriodValueUnitDays
At 2024-03-3185,645USD
At 2023-09-3062,248USD

Total liabilities

Recognized obligations at the reporting date. The definition and scope differ from interest-bearing debt.

PeriodValueUnitDays
At 2024-03-316,939,541USD
At 2023-09-307,860,732USD

Stockholders equity

The reported residual interest after liabilities. It is an accounting amount, not market capitalization.

PeriodValueUnitDays
At 2024-03-31-6,853,896USD
At 2023-12-31-6,429,176USD
At 2023-09-30-7,798,484USD
At 2023-03-31-5,726,692USD
At 2022-12-31-7,026,302USD
At 2022-09-30-4,653,066USD

Cash and cash equivalents

Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.

PeriodValueUnitDays
At 2024-03-319,812USD
At 2023-09-3021,415USD

Net income or loss

Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-492,594USD91
2023-10-01 to 2024-03-31810,999USD183
2023-01-01 to 2023-03-31453,764USD90
2022-10-01 to 2023-03-31-2,177,642USD182

Operating cash flow

Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.

PeriodValueUnitDays
2023-10-01 to 2024-03-31-101,103USD183
2022-10-01 to 2023-03-31-356,510USD182

Revenue

Revenue under this specific accounting concept. A missing value is not zero; filers can use other revenue concepts.

PeriodValueUnitDays
2024-01-01 to 2024-03-310USD91
2023-10-01 to 2024-03-310USD183
2023-01-01 to 2023-03-310USD90
2022-10-01 to 2023-03-310USD182

Financing cash flow

Net cash from financing activities, including borrowing, repayments and transactions with owners. A positive amount does not establish operating profitability.

PeriodValueUnitDays
2023-10-01 to 2024-03-3189,500USD183
2022-10-01 to 2023-03-31314,250USD182

Retained earnings or deficit

Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.

PeriodValueUnitDays
At 2024-03-31-66,091,467USD
At 2023-09-30-66,902,466USD

Basic weighted-average shares

Time-weighted shares used for basic earnings per share. This denominator differs from shares outstanding at a single reporting date.

PeriodValueUnitDays
2024-01-01 to 2024-03-3128,310,935shares91
2023-10-01 to 2024-03-3125,828,176shares183
2023-01-01 to 2023-03-3120,698,747shares90
2022-10-01 to 2023-03-3119,832,524shares182

Diluted weighted-average shares

Weighted-average shares used for diluted earnings per share. Potential shares are included under the applicable dilution rules, not simply added to outstanding shares.

PeriodValueUnitDays
2024-01-01 to 2024-03-3128,310,935shares91
2023-10-01 to 2024-03-31368,598,520shares183
2023-01-01 to 2023-03-3145,601,456shares90
2022-10-01 to 2023-03-3119,832,524shares182

Basic earnings per share

Reported earnings or loss per basic common share or unit. Inspect attribution, share classes and restatements before comparing periods. This is not a market return.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-0.02USD/shares91
2023-10-01 to 2024-03-310.03USD/shares183
2023-01-01 to 2023-03-310.02USD/shares90
2022-10-01 to 2023-03-31-0.11USD/shares182

Diluted earnings per share

Reported earnings or loss per share under dilution rules. Antidilutive instruments may be excluded. A diluted value can equal the basic value without implying no potential dilution.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-0.02USD/shares91
2023-10-01 to 2024-03-310USD/shares183
2023-01-01 to 2023-03-31-0.03USD/shares90
2022-10-01 to 2023-03-31-0.11USD/shares182

Share-based compensation expense

Reported noncash expense for share-based payment arrangements. Noncash treatment does not mean the awards have no economic cost to shareholders.

PeriodValueUnitDays
2023-10-01 to 2024-03-310USD183
2022-10-01 to 2023-03-31711,814USD182

Operating income or loss

Operating revenue less operating expenses for the reporting period. It excludes items outside the reported operating result and is not free cash flow.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-232,555USD91
2023-10-01 to 2024-03-31-490,101USD183
2023-01-01 to 2023-03-31-1,054,988USD90
2022-10-01 to 2023-03-31-1,572,106USD182

Interest expense

Borrowing costs recognized as interest expense. This is distinct from cash interest paid and may not include every capitalized borrowing cost.

PeriodValueUnitDays
2024-01-01 to 2024-03-31106,472USD91
2023-10-01 to 2024-03-31178,286USD183
2023-01-01 to 2023-03-31262,216USD90
2022-10-01 to 2023-03-31562,670USD182

Current liabilities

Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.

PeriodValueUnitDays
At 2024-03-316,939,541USD
At 2023-09-307,860,732USD

Current accounts payable

Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.

PeriodValueUnitDays
At 2024-03-31636,784USD
At 2023-09-30514,686USD

Operating expenses

Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.

PeriodValueUnitDays
2024-01-01 to 2024-03-31232,555USD91
2023-10-01 to 2024-03-31490,101USD183
2023-01-01 to 2023-03-311,054,988USD90
2022-10-01 to 2023-03-311,572,106USD182

Gross profit

Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.

PeriodValueUnitDays
2024-01-01 to 2024-03-310USD91
2023-10-01 to 2024-03-310USD183
2023-01-01 to 2023-03-310USD90
2022-10-01 to 2023-03-310USD182

Cost of revenue

Costs attributed to goods produced and sold and services provided during the period. This is not the sum of every operating expense.

PeriodValueUnitDays
2024-01-01 to 2024-03-310USD91
2023-10-01 to 2024-03-310USD183
2023-01-01 to 2023-03-310USD90
2022-10-01 to 2023-03-310USD182

Selling, general and administrative expense

Selling and general administrative costs reported under this concept. It is an expense category, not a substitute for total operating expenses.

PeriodValueUnitDays
2024-01-01 to 2024-03-31196,280USD91
2023-10-01 to 2024-03-31404,129USD183
2023-01-01 to 2023-03-311,013,952USD90
2022-10-01 to 2023-03-311,496,106USD182

Research and development expense

Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.

PeriodValueUnitDays
2024-01-01 to 2024-03-3136,275USD91
2023-10-01 to 2024-03-3185,972USD183
2023-01-01 to 2023-03-3141,036USD90
2022-10-01 to 2023-03-3176,000USD182

Common shares outstanding

Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.

PeriodValueUnitDays
At 2024-03-3130,512,014shares
At 2023-09-3021,744,209shares

Cash including restricted cash

Cash, cash equivalents and restricted cash as reported in the cash flow reconciliation. Restricted amounts are not freely available, so this is not the same as unrestricted cash.

PeriodValueUnitDays
At 2024-03-319,812USD
At 2023-09-3021,415USD
At 2023-03-3121,991USD
At 2022-09-3064,251USD

Accrued current liabilities

Current obligations accrued for goods and services received but not yet invoiced or paid. This is one component of current liabilities, not all short-term obligations.

PeriodValueUnitDays
At 2024-03-3122,895USD
At 2023-09-3011,154USD

Net income available to common stockholders

Net income after preferred dividends and similar adjustments, the numerator for basic earnings per share. It can be lower than reported net income.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-492,594USD91
2023-10-01 to 2024-03-31810,999USD183
2023-01-01 to 2023-03-31409,523USD90
2022-10-01 to 2023-03-31-2,221,883USD182

Nonoperating income or expense

Total nonoperating income or expense, which can include interest, investment results and other items. A positive value is not operating profit.

PeriodValueUnitDays
2024-01-01 to 2024-03-31-260,039USD91
2023-10-01 to 2024-03-311,301,100USD183
2023-01-01 to 2023-03-311,508,752USD90
2022-10-01 to 2023-03-31-605,536USD182

Interest paid, net

Cash interest paid during the period, net of amounts capitalized where the filer reports it that way. It differs from interest expense recognized.

PeriodValueUnitDays
2023-10-01 to 2024-03-310USD183
2022-10-01 to 2023-03-3117,711USD182

Proceeds from issuing common stock

Cash received from issuing common stock during the period. It is gross of costs only where the filer reports it so, and it does not include noncash issuances.

PeriodValueUnitDays
2023-10-01 to 2024-03-310USD183
2022-10-01 to 2023-03-3150,000USD182

Change in accounts payable

The cash flow adjustment for the change in payables during the period. A positive value under this concept means payables grew and added to operating cash flow.

PeriodValueUnitDays
2023-10-01 to 2024-03-31126,570USD183
2022-10-01 to 2023-03-3171,147USD182

Inspect the source

Entity
NovAccess Global Inc. / CIK 0001039466
Captured
2026-09-21T17:18:07.633Z
SEC response SHA-256
eb5e8ada45abbdf8332dd8033cd691410a30e1ad3e31e78fd78deb69ce06d877

Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON

Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.

Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.

Use this in research

A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.

These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.

Research methodology · Execution and cost assumptions · Check backtest overfitting

Build with the open-source tools

Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.

Read the published dataset with Python
import json
from urllib.request import urlopen

with urlopen("https://canlicapital.com/company-data/0001039466.json") as response:
    record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
    print(concept["tag"], next(iter(concept["observations"])))